(2) Systemic Lupus Erythematosus.
| Thyroid cancer (−), Mean ± SD | Thyroid cancer (+), Mean ± SD | P | |
|---|---|---|---|
| TSH (µU/mL) | 1.38 ± 0.86 | 1.30 ± 0.26 | .869 |
| FT3 (pg/mL) | 2.67 ± 0.78 | 2.50 ± 0.53 | .720 |
| FT4 (ng/dL) | 1.11 ± 0.17 | 1.01 ± 0.12 | .345 |
| Thyroglobulin (ng/mL) | 19.44 ± 13.35 | 13.53 ± 13.04 | .480 |
| Anti-thyroglobulin (IU/mL) | 14.82 ± 10.07 | 12.33 ± 2.08 | .679 |
| Anti-TPO (IU/mL) | 10.87 ± 9.85 | 10.66 ± 7.37 | .973 |
| TSHR antibody (IU/L) | 2.07 ± 6.18 | 0.50 ± 0.00 | .730 |
Abbreviations: TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine; TPO, thyroid peroxidase; TSHR, thyroid-stimulating hormone receptor.